Product Description
Kyprolis Injection
Saintroy Lifescience exporter,wholesaler and contract manufacturer is a privately owned cutting edge healthcare solution provider company based in India.
Brand Name- Kyprolis Injection, Contain Carfilzomib Injection. Strength- 60 mg. Pack- 1 vial per pack. Manufactured by Amgen, Origin of Country-USA.
USE- Carfilzomib Injection is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Kyprolis is used to treat multiple myeloma.
Effective Cancer TreatmentKyprolis Injection is a clinically approved therapy for multiple myeloma, helping to control and reduce the progression of cancerous cells. Its unique action on cancer cells makes it a preferred option among oncologists for eligible patients.
Manufactured and Supplied in IndiaWe are a trusted name in India for manufacturing, supplying, and exporting Kyprolis Injection. Our robust distribution network ensures that hospitals, clinics, and pharmacies receive authentic medications, supported with verified storage and handling guidelines.
Safe Usage GuidelinesKyprolis Injection must only be administered by trained healthcare professionals. Proper dosage and protocol minimize side effects and ensure the best possible outcomes. Patients are advised to follow all medical guidance closely during their treatment course.
FAQ's of Kyprolis Injection:
Q: How should Kyprolis Injection be administered for multiple myeloma treatment?
A: Kyprolis Injection should be administered intravenously by a qualified healthcare professional in a clinical or hospital setting, following the dosage and schedule prescribed by the doctor.
Q: What are the benefits of using Kyprolis Injection for patients with multiple myeloma?
A: Kyprolis Injection helps slow the growth and spread of cancer cells in multiple myeloma, improving patient outcomes and quality of life when used as part of a prescribed cancer treatment plan.
Q: When is Kyprolis Injection typically recommended during cancer therapy?
A: Doctors usually recommend Kyprolis Injection in patients diagnosed with multiple myeloma, especially when other treatments have not produced adequate results or in combination with other therapies.
Q: Where should Kyprolis Injection be stored before use?
A: Kyprolis Injection should be stored in a cool, dry place, away from direct sunlight, to maintain its effectiveness until administration.
Q: What is the process for sourcing Kyprolis Injection in India?
A: Kyprolis Injection can be procured from licensed dealers, distributors, suppliers, and pharmacies across India, ensuring buyers receive genuine and quality-assured medication.
Q: What precautions should be observed during the use of Kyprolis Injection?
A: Patients should closely follow their doctor's guidelines, report any side effects immediately, and avoid missing scheduled doses to maximize treatment efficacy and safety.